The invention relates to a combination comprising the N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide； and one or more pharmaceutically active agents； pharmaceutical compositions comprising said combination； methods of treatment comprising said combination； processes for making said combination； and a commercial package comprising said combination.
